Berkshire Asset Management LLC PA bought a new position in shares of MetLife, Inc. (NYSE:MET - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor bought 3,739 shares of the financial services provider's stock, valued at approximately $290,000.
Other large investors also recently made changes to their positions in the company. Quantbot Technologies LP bought a new position in shares of MetLife in the first quarter valued at $1,008,000. Cornerstone Select Advisors LLC grew its position in shares of MetLife by 20.5% in the 1st quarter. Cornerstone Select Advisors LLC now owns 3,775 shares of the financial services provider's stock valued at $303,000 after acquiring an additional 641 shares during the period. Edgar Lomax Co. VA increased its stake in shares of MetLife by 91.6% during the 1st quarter. Edgar Lomax Co. VA now owns 294,605 shares of the financial services provider's stock worth $23,654,000 after purchasing an additional 140,855 shares during the last quarter. Aptus Capital Advisors LLC increased its stake in shares of MetLife by 5.6% during the 1st quarter. Aptus Capital Advisors LLC now owns 12,663 shares of the financial services provider's stock worth $1,017,000 after purchasing an additional 676 shares during the last quarter. Finally, Northern Trust Corp raised its holdings in shares of MetLife by 0.8% in the 1st quarter. Northern Trust Corp now owns 7,109,423 shares of the financial services provider's stock valued at $570,816,000 after purchasing an additional 57,221 shares during the period. Institutional investors and hedge funds own 94.99% of the company's stock.
MetLife Stock Performance
MetLife stock traded up $2.1760 during midday trading on Friday, hitting $81.4160. The company's stock had a trading volume of 3,502,666 shares, compared to its average volume of 3,596,835. The company has a debt-to-equity ratio of 0.57, a current ratio of 0.16 and a quick ratio of 0.16. The company has a market cap of $54.14 billion, a price-to-earnings ratio of 13.80, a PEG ratio of 0.73 and a beta of 0.85. MetLife, Inc. has a 1-year low of $65.21 and a 1-year high of $89.05. The company has a 50-day moving average price of $77.91 and a two-hundred day moving average price of $78.49.
MetLife (NYSE:MET - Get Free Report) last announced its earnings results on Wednesday, August 6th. The financial services provider reported $2.02 EPS for the quarter, missing the consensus estimate of $2.32 by ($0.30). The business had revenue of $17.34 billion for the quarter, compared to the consensus estimate of $18.58 billion. MetLife had a return on equity of 19.88% and a net margin of 5.83%.The firm's revenue for the quarter was down 2.7% compared to the same quarter last year. During the same period in the prior year, the business posted $2.28 earnings per share. As a group, sell-side analysts predict that MetLife, Inc. will post 9.65 earnings per share for the current year.
MetLife declared that its board has approved a share buyback plan on Wednesday, April 30th that authorizes the company to repurchase $3.00 billion in shares. This repurchase authorization authorizes the financial services provider to buy up to 5.9% of its shares through open market purchases. Shares repurchase plans are typically an indication that the company's leadership believes its shares are undervalued.
MetLife Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 9th. Stockholders of record on Tuesday, August 5th will be given a dividend of $0.5675 per share. This represents a $2.27 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date is Tuesday, August 5th. MetLife's dividend payout ratio is presently 38.47%.
Analyst Ratings Changes
MET has been the topic of a number of recent analyst reports. Wall Street Zen downgraded MetLife from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th. JPMorgan Chase & Co. boosted their target price on MetLife from $86.00 to $95.00 and gave the stock an "overweight" rating in a report on Tuesday, July 8th. Keefe, Bruyette & Woods cut their price target on MetLife from $94.00 to $92.00 and set an "outperform" rating for the company in a report on Monday, August 11th. Barclays upped their price objective on shares of MetLife from $88.00 to $94.00 and gave the company an "overweight" rating in a report on Monday, July 7th. Finally, UBS Group cut their target price on shares of MetLife from $94.00 to $91.00 and set a "buy" rating for the company in a research note on Thursday, August 7th. Ten research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, MetLife currently has an average rating of "Moderate Buy" and an average price target of $95.60.
Read Our Latest Research Report on MetLife
MetLife Company Profile
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
See Also

Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.